Can You Have Hip Replacement With Osteoporosis?

Hip replacement surgery is routinely performed on people with osteoporosis, and for many of them it remains the best option for relieving severe hip pain or recovering from a fracture. The procedure does carry extra considerations when bone is thinner and weaker than normal, from how the implant is anchored to which medications are used afterward. But “you have osteoporosis” is not a reason a surgeon would cancel the operation; it is a reason they would plan it differently.

Why Osteoporosis Comes Up So Often in Hip Replacement

The overlap between the two conditions is hard to avoid. Hip replacements are most commonly done for severe arthritis or after a broken hip, and both of those situations cluster in older adults whose bone density has already declined. A narrative review in Hip & Pelvis notes that osteoporosis and osteopenia affect a large share of patients coming in for hip arthroplasty, whether they are having it for arthritis or for a femoral neck fracture.¹ Many patients don’t even know they have osteoporosis until the surgical workup reveals it. One study found that CT scans done as part of robotic-assisted hip replacement planning identified 13 osteopenic and 8 osteoporotic patients who had no prior bone density data on file.² So for surgeons, managing weak bone during hip replacement is not an unusual challenge; it is a regular part of the job.

The Real Risks That Osteoporosis Adds

Low bone density does not make hip replacement impossible, but it does change the risk profile in specific ways. The two complications that come up most in the research are periprosthetic fractures and implant loosening. A periprosthetic fracture is a break in the bone around the implant, either during surgery when the implant is being pressed or hammered into place, or sometime afterward during normal activity. According to a 2025 review, periprosthetic fractures occur in roughly 0.1% to 3.5% of hip replacement patients overall, and osteoporosis is one of the key risk factors alongside older age, female sex, and rheumatoid arthritis.³

A prospective study looking specifically at outcomes found that patients with osteoporosis had higher odds of a longer hospital stay, being discharged to a facility rather than home, being readmitted within 90 days, and needing a reoperation within a year. They were also less likely to reach satisfying levels of pain relief and physical function at the one-year mark compared to patients without osteoporosis.⁴ None of that means the surgery fails; it means recovery tends to be slower and more resource-intensive, and expectations should be set accordingly.

Cemented Versus Cementless Implants

This is where most of the debate lives. In a hip replacement, the femoral stem is a metal rod that fits down into the thighbone. It can be held in place with bone cement (a quick-setting polymer) or pressed in without cement so that bone grows directly onto the implant surface over time. The general recommendation for osteoporotic patients has long favored cemented stems, on the reasoning that weak bone may not grip a cementless implant tightly enough.¹

A retrospective study with about five years of follow-up compared cemented and uncemented stems in older patients with primary osteoporosis. Hip function scores were consistently better in the cemented group from three months onward, loosening rates were lower (about 17% cemented vs. 26% uncemented), and the early revision rate was roughly half in the cemented group.⁵ A randomized trial in elderly patients with displaced femoral neck fractures was stopped early after an interim analysis found substantially more complications in the uncemented group, including dislocations and periprosthetic fractures.⁶

The picture is not quite that simple, though. A large registry-based analysis found no difference in either aseptic revision or periprosthetic fracture rates at five years between cemented and cementless fixation in osteoporotic patients. The cemented group actually had a higher rate of mechanical loosening.⁷ And a separate study directly challenged the assumption that osteoporosis predisposes patients to more fractures and loosening after cementless hip replacement.⁸

So the “cemented is always safer” rule is more nuanced than textbooks once suggested. The answer depends heavily on the specific patient, how severe the bone loss is, what implant design is used, and whether the surgery is for arthritis or a fracture. Surgeons increasingly choose on a case-by-case basis rather than applying a blanket policy.

How Surgeons Assess Your Bone Before Surgery

If you are heading into a hip replacement, your surgeon needs to know how much usable bone is available to work with. Bone mineral density measured by a DXA scan (the standard osteoporosis test) gives one layer of information, and research confirms that those measurements correlate with what surgeons find during the operation, including the thickness of the cortical bone where the femoral neck is cut.⁹

Surgeons also classify bone quality by looking at the shape and thickness of the femoral canal on X-rays using what is called the Dorr classification. The categories run from A (thick, strong cortical walls) through C (thin walls, a wide canal). This classification has real consequences for surgical planning. In a multicenter study, the periprosthetic fracture rate with cementless implants climbed from about 2% in type A bone to nearly 16% in type C bone.¹⁰ That steep jump explains why many surgeons default to cemented stems in Dorr C bone, or at minimum select cementless designs specifically engineered for wide, thin-walled canals.

Interestingly, when a CT scan is already being done for robotic-assisted surgery, it can double as a bone density screening tool, catching osteoporosis that might otherwise go undiagnosed. In one series, every patient found to have osteoporosis by CT analysis received a cemented stem regardless of which surgical technique was being used.²

Implant Designs That Work Better in Weak Bone

When a cementless stem is used in osteoporotic bone, not all stem designs are equal. The narrative review in Hip & Pelvis notes that ribbed stems, straight tapered stems, stems with contact along the inner (medial calcar) portion of the bone, and titanium-composed stems are recommended to reduce bone mineral density loss around the implant. The review also warns against placing the stem in a varus position, meaning tilted inward, because that increases stress on already fragile bone.¹

One study looked at a long, cylindrical tapered cementless stem (the Wagner SL design) in patients with Dorr type C bone and found that its shape allowed reliable stability by making close contact along the full length of the wide canal.¹¹ A different study evaluated double-tapered stems in osteoporotic patients and found that early settling of the implant was no worse than in patients with normal bone, with all stems achieving stable fixation at final follow-up.¹²

Hydroxyapatite coatings and collars are two other design features that come up. Hydroxyapatite is a calcium-phosphate material applied to the implant surface to encourage bone to bond with it. A study of fully coated, collared stems in elderly patients reported only about a 2% rate of intraoperative periprosthetic fracture and a 4% rate of meaningful settling, with Dorr canal type not significantly affecting either risk.¹³ The collar sits on the cut surface of the femoral neck and theoretically shares load, though the same study found the difference between collared and uncollared stems was not statistically significant.

Keeping the Socket Stable

Most of the conversation about osteoporosis and hip replacement focuses on the femoral stem, but the acetabular cup (the socket side of the joint) faces its own challenges. In osteoporotic bone, the pelvis may not grip a press-fit cup as firmly, and if the patient is having surgery because of an acetabular fracture, the surgeon has even less intact bone to work with.

Lab testing showed that when bone density was reduced by about 65%, an acetabular cup reconstructed with screws and bioabsorbable bone cement performed similarly to a healthy bone model under lighter loads but showed increased displacement and rotation as loads climbed toward the upper range.¹⁴ That means supplemental screws become more important in osteoporotic patients. Experimental work confirms that acetabular screws do enhance initial cup fixation, particularly when bone stock is suboptimal, though locking screws did not outperform standard screws.¹⁵

For the most demanding scenario, hip replacement done at the same time as an osteoporotic acetabular fracture, cup-cage constructs using oversized cups have been studied. In a small series, the majority of acetabular components remained stable despite achieving contact with only 15% to 27% of the pelvic bone surface. Three out of ten components did migrate beyond the limits that usually predict future loosening in primary hip replacements, leading the surgical team to add ischial and pubic ramus screws to their technique going forward.¹⁶

Medications That Help Protect the Implant

Osteoporosis treatment does not stop just because you have had a hip replacement. If anything, it becomes more important, since preserving bone around the new implant is critical for its long-term survival.

Bisphosphonates are the most-studied drugs in this context. A systematic review and meta-analysis found that bisphosphonates preserved periprosthetic bone density by a meaningful margin, with the benefit persisting at two to four years and beyond five years after hip replacement. In osteoporotic hip replacement patients specifically, zoledronic acid (an intravenous bisphosphonate) was the most consistently effective, particularly in the bone zones closest to the implant.¹⁷ A separate review noted that bisphosphonates may boost early bone ingrowth, reduce post-surgical bone density loss, and extend implant longevity by lowering the risk of revision for loosening. Continuing bisphosphonates for about a year after surgery appeared to provide the greatest benefit, with diminishing returns beyond two years.¹⁸

Teriparatide, an injectable drug that stimulates new bone formation rather than just slowing resorption, has also been studied in joint replacement patients. A small retrospective study of 32 patients who received teriparatide after joint replacement reported no drug-related adverse events or post-surgical complications during follow-up.¹⁹ The evidence base for teriparatide in this setting is still thin, but the rationale is promising: actively building bone around an implant rather than just preventing its loss.

What Recovery Looks Like With Osteoporosis

Recovery is broadly similar to what any hip replacement patient goes through, with a few adjustments. One practical advantage of hip replacement over internal fixation (plates and screws to repair a broken hip without replacing the joint) is that replacement typically allows full weight-bearing much sooner, which matters enormously for older adults at risk of the rapid deconditioning that bed rest causes.²⁰

As noted earlier, the prospective cohort data shows that osteoporotic patients use more healthcare resources in the first year: longer initial hospital stays, higher readmission rates, and a greater chance of discharge to a skilled nursing facility rather than home.⁴ Higher T-scores (meaning better bone density) were associated with lower odds of these setbacks, which underscores why treating osteoporosis before surgery, when there is time, can improve the outcome even though the surgery itself is not off the table.

Surgical approach may also influence recovery. A cohort study of older adults who underwent hip replacement after osteoporotic femur fracture found that those who had the posterolateral approach showed less chronic pain, better overall function, and greater hip and knee mobility compared to those who had the anterolateral approach.²¹ Approach choice depends on many factors beyond bone density, but it is one more variable that an experienced surgical team will weigh.

When a Revision Is Needed Down the Road

Revision hip replacement, replacing a worn-out or failed implant with a new one, is more challenging than the original surgery for anyone. In osteoporotic patients, the concern is compounded because bone loss may have worsened around the original implant over the years, leaving even less stock for the new components to grip.

On the acetabular side, massive bone loss can be addressed with custom-made components shaped from CT scans to match the patient’s pelvic anatomy. In one series of 57 revision patients with severe bone deficiency, about 81% achieved healing of pelvic discontinuity, and only about 2% needed re-revision for loosening of the acetabular component. A separate series with 10-year follow-up of 20 hips with massive bone loss and pelvic discontinuity found that none of the custom components were revised for loosening, and healing was evident on imaging in 90% of cases.²² These custom solutions are expensive and require longer planning, but they expand the options considerably for patients who would otherwise face very limited choices.

Revision surgery also highlights why ongoing osteoporosis treatment after the first hip replacement matters. The more bone you preserve around the original implant over the years, the more your surgeon has to work with if a revision ever becomes necessary. Bisphosphonate therapy in the first year or two after the initial surgery is not just about keeping that implant in place; it is insurance for the future.

Anesthesia Considerations for Osteoporotic Patients

The anesthesia question is not unique to osteoporosis, but it overlaps with the profile of the typical osteoporotic hip replacement patient: older, often with other medical conditions, sometimes frail. A review of perioperative outcomes found that regional anesthesia (spinal or epidural) was associated with better results for overall mortality, blood clot risk, blood loss, and transfusion requirements compared to general anesthesia in hip surgery patients.²³ For an osteoporotic patient who may already face a slightly higher complication rate, minimizing additional surgical stress through anesthetic technique is a small but meaningful edge. This is a conversation worth having with your anesthesiologist before the day of surgery.